TAE Life Sciences to Present Groundbreaking Developments in Cancer Drug Development at Biotech Showcase 2024

Presentation will include results of BTS drug study for BNCT and details about new Fc-engineered antibodies for site-specific conjugation SAN FRANCISCO, Dec. 27, 2023 /PRNewswire/ — At the forefront of pioneering advancements in the field of radiation oncology, TAE Life Sciences is set…

Click here to view original post